Evidence map›Paper›PMID 41735628›Full record

ReviewNature reviews. Microbiology2026

Varicella zoster virus and the central nervous system.

Benson Ogunjimi, Charlotte Warren-Gash, Werner J D Ouwendijk, Judith Breuer, Trine H Mogensen, David M Koelle

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Varicella zoster virus infection.Nature reviews. Disease primers · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Benson OgunjimiAntwerp Center for Translational Immunology and Virology (ACTIV), Centre for Health Economics Research and Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium. benson@uantwerp.be.ORCID http://orcid.org/0000-0002-0831-2063
Charlotte Warren-GashFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Werner J D OuwendijkDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-8393-296X
Judith BreuerInfection, Immunity and Inflammation Department, Great Ormond Street Institute of Child Health, University College London, London, UK.ORCID http://orcid.org/0000-0001-8246-0534
Trine H MogensenDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-1853-9704
David M KoelleDepartment of Medicine, University of Washington, Seattle, WA, USA.

Funding

Cutaneous Pathogen-Specific Tissue Resident Memory T Cells in Human AgingR01AG064800 · NIA · UNIVERSITY OF WASHINGTON · PI KOELLE, DAVID M · 2019 to 2023
$3.5M
NIA NIH HHS R01 AG064800
6 · The paper itself

Abstract

Varicella zoster virus (VZV) causes varicella, also known as chickenpox, after which VZV remains latent in neural ganglia. VZV reactivation can result in herpes zoster, also known as shingles. In addition to its well-known effects on the peripheral nervous system, reports increasingly suggest that VZV can have potentially devastating effects on the central nervous system (CNS). Several epidemiological studies indicate that VZV reactivation is associated with stroke and interest is growing in potential associations of VZV with dementia. In the past 5-6 years, vaccination against herpes zoster has been reported to reduce the risk of developing cardiovascular events (including stroke) and dementia in observational studies, although interpretation of their findings is hindered by complex methodological challenges. This Review considers the relationship between VZV and the CNS from a multidisciplinary perspective that focuses on VZV physiology and immunity. The strengths and weaknesses of published studies are discussed, and areas for future investigation that remain to be addressed before the links between VZV and CNS conditions can be considered definitive and medically actionable are highlighted. Finally, these insights are integrated into an overarching conclusion that addresses potential consequences of the connection between VZV and the CNS for both public health and healthy ageing.

Indexed as

Central Nervous SystemChickenpoxHerpesvirus 3, HumanHerpes ZosterAnimalsHumansVirus Activation

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.